ANI PHARMACEUTICALS INC — Director's Dealing 2014

Mar 21, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ANI PHARMACEUTICALS INC (ANIP)
CIK: 0001023024
Period of Report: 2014-03-20

Reporting Person: MARSHBANKS TRACY (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-03-20	Common Stock	S	11361	$31.5408	Disposed	523296	Indirect
2014-03-20	Common Stock	S	4612	$31.5408	Disposed	212448	Indirect
2014-03-20	Common Stock	S	177	$31.5408	Disposed	8173	Indirect
2014-03-21	Common Stock	S	3951	$31.0606	Disposed	519345	Indirect
2014-03-21	Common Stock	S	1604	$31.0606	Disposed	210844	Indirect
2014-03-21	Common Stock	S	62	$31.0606	Disposed	8111	Indirect

Footnotes

F1: Held by: FA Private Equity Fund IV, L.P., of which the Reporting Person may be deemed to be a beneficial owner pursuant to rule 16a-1(a)(1).

F2: Held by: The Productivity Fund IV Liquidating Trust, of which the Reporting Person may be deemed to be a beneficial owner pursuant to rule 16a-1(a)(1).

F3: Held by: The Productivity Fund IV Advisors Fund Liquidating Trust, of which the Reporting Person may be deemed to be a beneficial owner pursuant to rule 16a-1(a)(1).